#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13764	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2064	662.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	828	C	772	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25374	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	689.2	0	.	n	.	0	T695C	SNP	695	695	T	1082	1082	C	773	C,A	729,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25374	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	689.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1724	1724	A	853	A,G	804,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25374	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	689.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2358	2358	C	838	C	776	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25374	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	689.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2432	2432	A	775	A	739	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25374	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	689.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2984	2984	C	769	C,A	728,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1984	folP	855	855	100.0	folP.l6.c30.ctg.1	1638	120.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1022	1024	AGC	208;206;209	A;G;C	192;190;190	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5934	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3412	173.4	1	SNP	p	S91F	1	.	.	271	273	TTC	599	601	TTC	211;213;212	T;T;C	202;204;202	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5934	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3412	173.4	1	SNP	p	G95N	0	.	.	283	285	GGC	611	613	GGC	218;213;210	G,T;G;C	204,1;202;196	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5934	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3412	173.4	1	SNP	p	D95G	1	.	.	283	285	GGC	611	613	GGC	218;213;210	G,T;G;C	204,1;202;196	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1694	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1246	135.1	1	SNP	p	G45D	0	.	.	133	135	GGC	454	456	GGC	232;232;232	G;G;C	214;214;213	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	836	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1019	81.9	0	.	n	.	0	A197.	DEL	197	197	A	582	582	A	203	A	194	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5468	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2786	194.9	1	SNP	p	D86N	0	.	.	256	258	GAC	474	476	GAC	206;204;206	G;A;C	191;190;195	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5468	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2786	194.9	1	SNP	p	R87W	0	.	.	259	261	CGT	477	479	CGT	208;211;214	C,A;G,A;T	196,1;198,1;202	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5468	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2786	194.9	1	SNP	p	R87I	0	.	.	259	261	CGT	477	479	CGT	208;211;214	C,A;G,A;T	196,1;198,1;202	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5468	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2786	194.9	1	SNP	p	S87R	1	.	.	259	261	CGT	477	479	CGT	208;211;214	C,A;G,A;T	196,1;198,1;202	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5468	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2786	194.9	1	SNP	p	S88P	0	.	.	262	264	TCC	480	482	TCC	219;225;227	T;C;C	204;210;213	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4546	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2591	174.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1498	1500	GGC	239;238;239	G,T;G;C	221,1;219;220	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1348	1350	GCA	228;230;228	G;C;A	208;208;212	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1351	1353	ATC	230;230;232	A;T;C	211;210;209	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1363	1365	GTG	228;226;227	G;T;G	211;207;206	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1363	1365	GTG	228;226;227	G;T;G	211;207;206	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1867	1869	ACC	240;241;242	A;C;C	219;229;227	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1921	1923	GCG	213;209;210	G;C,G;G	179;161,1;171	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1921	1923	GCG	213;209;210	G;C,G;G	179;161,1;171	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2044	2046	AGC	183;180;177	A;G;C,G	169;163;161,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2053	2055	GGC	177;178;176	G;G;C	160;162;160	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4122	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2525	162.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2071	2073	CCG	154;157;151	C,G;C;G	110,6;115;109	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5686	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3011	188.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1601	1603	CCG	240;239;240	C;C;G	211;219;213	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2396	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1783	133.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	492	492	C	179	C,A	172,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2804	porB1b	1035	1035	98.76	porB1b.l15.c30.ctg.1	1472	188.8	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	922	922	T	224	T	213	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2804	porB1b	1035	1035	98.76	porB1b.l15.c30.ctg.1	1472	188.8	1	SNP	p	G120K	0	.	.	358	360	GGT	649	651	GGT	241;240;240	G;G;T,C	220;219;215,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2804	porB1b	1035	1035	98.76	porB1b.l15.c30.ctg.1	1472	188.8	1	SNP	p	A121N	0	.	.	361	363	GCC	652	654	GCC	237;236;233	G;C;C	217;214;214	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2804	porB1b	1035	1035	98.76	porB1b.l15.c30.ctg.1	1472	188.8	1	SNP	p	A121D	0	.	.	361	363	GCC	652	654	GCC	237;236;233	G;C;C	217;214;214	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9946	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4803	206.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1114	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1004	110.4	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	214;212;218	A;T;G,C	205;200;206,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
